These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17484228)

  • 61. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 62. Imiquimod: a cytokine inducer.
    Dahl MV
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
    [No Abstract]   [Full Text] [Related]  

  • 63. Imiquimod in clinical practice.
    Edwards L
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S12-7. PubMed ID: 10861102
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Ali SM; Kwah MS
    J Infect; 2000 Sep; 41(2):148-51. PubMed ID: 11023759
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An audit of patients who have received imiquimod cream 5% for the treatment of anogenital warts.
    Maitland JE; Maw R
    Int J STD AIDS; 2000 Apr; 11(4):268-70. PubMed ID: 10772094
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
    Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women.
    Garland SM; Waddell R; Mindel A; Denham IM; McCloskey JC
    Int J STD AIDS; 2006 Jul; 17(7):448-52. PubMed ID: 16820073
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of imiquimod in anogenital warts from HIV-positive men.
    Herrera S; Correa LA; Wolff JC; Gaviria A; Tyring SK; Sanclemente G
    J Clin Virol; 2007 Jul; 39(3):210-4. PubMed ID: 17513167
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Florid anogenital warts in a 7-month-old boy with rapid response to imiquimod.
    Bhandari M; Khunger N; Khullar G; Mittal S; Yadav AK; Bhargava A
    Dermatol Ther; 2022 Apr; 35(4):e15329. PubMed ID: 35075732
    [No Abstract]   [Full Text] [Related]  

  • 70. Determination of the area of skin capable of being covered by the application of 250 mg of 5% imiquimod cream.
    Berman B; Ricotti CA; Cazzaniga A; Davis SC
    Dermatol Surg; 2004 May; 30(5):784-6. PubMed ID: 15099325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Successful treatment of massive anogenital warts in a two-year-old boy with imiquimod and cimetidine immunotherapy.
    Cohler M; Schaffer JV
    Pediatr Infect Dis J; 2009 Dec; 28(12):1141. PubMed ID: 19935275
    [No Abstract]   [Full Text] [Related]  

  • 72. Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women.
    Trofatter KF; Ferenczy A; Fife KH
    Int J Gynaecol Obstet; 2002 Feb; 76(2):191-3. PubMed ID: 11818121
    [No Abstract]   [Full Text] [Related]  

  • 73. Imiquimod in dermatology: an overview.
    Hanna E; Abadi R; Abbas O
    Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of genital warts with an immune-response modifier (imiquimod).
    Beutner KR; Spruance SL; Hougham AJ; Fox TL; Owens ML; Douglas JM
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):230-9. PubMed ID: 9486679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cost-effectiveness of imiquimod for anogenital warts.
    Birley H; Clark F; Sparks R
    Int J STD AIDS; 2002 Sep; 13(9):647; author reply 647-8. PubMed ID: 12230931
    [No Abstract]   [Full Text] [Related]  

  • 76. Imiqimod in clinical practice.
    Trofatter KF
    Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imiquimod as an immune response modulator in infectious conditions.
    Skinner RB
    Postgrad Med; 2002 Dec; 112(6 Suppl Using):8-16. PubMed ID: 19667608
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using imiquimod for genital warts in female patients.
    Cox JT; Petry KU; Rylander E; Roy M
    J Womens Health (Larchmt); 2004 Apr; 13(3):265-71. PubMed ID: 15130255
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New patient-applied therapy for anogenital warts is rated favourably by patients.
    O'Mahony C; Law C; Gollnick HP; Marini M
    Int J STD AIDS; 2001 Sep; 12(9):565-70. PubMed ID: 11516364
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children.
    Grussendorf-Conen EI; Jacobs S
    Pediatr Dermatol; 2002; 19(3):263-6. PubMed ID: 12047649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.